Drawing for Serial No. 87759623

USPTO serial 87759623

Serial No. 87759623

Reviewed by CopyMark Law Group

Reg. 5545324Status 701Registered
Filing date
Status date
Registration date
Aug 21, 2018
Examiner
LOOK, JEFFREY J
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with Serial No. 87759623?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

He Li

He Li FIDELI LAW PLLC5 Peach Leaf CtNorth Potomac, MD 20878United States

Goods and services

ClassDescriptionStatusFirst use
005Cough treatment preparations; [ Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietetic foods, namely, pasta and crackers adapted for medical use; Herbal teas for medicinal purposes; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Medicinal drinks; ] Medicinal herbal extracts for medical purposes; Medicines for the treatment of gastrointestinal diseases; [ Mineral food supplements; Nutraceuticals for use as a dietary supplement for promoting digestion; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish and meat; Nutritional supplements; ] Nutritional supplements in the form of capsules, tablets, caplets; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Preparations for treating coldsACTIVEFeb 3, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 26, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Mar 26, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 26, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 20, 2024ES8RTEAS SECTION 8 RECEIVED—
Aug 21, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 21, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 5, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 5, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 2, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 30, 2018DOCKASSIGNED TO EXAMINER—
Jan 31, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 30, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance